| Product Name | MF | CAS | Details |
|---|
| UDP-2-deoxy-2-fluoro-D-glucose sodium salt | C15H23FN2O16P2 | 67341-43-9 | Details |
| PRR15 antibody | Details |
| RAB3C antibody | Details |
| 1-Bromo-4-(bromomethyl)-2-chlorobenzene | C7H5Br2Cl | 68120-44-5 | Details |
| 2-Benzoyl-5-fluoropyridine | C12H8FNO | 1427379-15-4 | Details |
| 3-Methylpyrazolo[1,5-a]pyridine-2-carboxylic acid | C9H8N2O2 | 1398584-50-3 | Details |
| 6-Ethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride | C11H16ClNO | 63905-72-6 | Details |
| 3-({1,3-Diethyl-2-oxo-1H,2H,3H-imidazo[4,5-b]pyridin-5-yl}carbamoyl)propanoic acid | C14H18N4O4 | 1110717-65-1 | Details |
| tert-Butyl 6-fluoropyridine-2-carboxylate | C10H12FNO2 | 1053656-65-7 | Details |
| H-SSSPPVVTSSSHSRAPC-OH | Details |
| 4,6-Dimethyl-2-hydroxypyrimidine | C6H8N2O | 108-79-2 | Details |
| 2-(5-Bromo-4-formyl-2-methoxyphenoxy)acetamide | C10H10BrNO4 | 486994-16-5 | Details |
| [1,1-Bis(diphenylphosphino-kP)ferrocene]chloro[(1,2,3-η)-1-phenyl-2-propen-1-yl]nickel | C43H28ClFeNiP2 | 1443644-08-3 | Details |
| Etretinate | C23H30O3 | 54350-48-0 | Details |
| Apelin-36 Human | C184H295N69O42R2S | 252642-12-9 | Details |
| 1-[2-Fluoro-6-(2-methoxyethoxy)phenyl]ethan-1-one | C11H13FO3 | 1019625-48-9 | Details |
| 3,5-Dimethoxycinnamic acid | C11H12O4 | 16909-11-8 | Details |
| (4,6-Dimethoxypyrimidin-2-yl)methanamine | C7H11N3O2 | 771582-35-5 | Details |
| GAD1 antibody | Details |
| LAX1 Blocking Peptide | Details |
| 5-Methyl-4-(phenoxymethyl)furan-2-carboxylic acid | C13H12O4 | 938143-64-7 | Details |
| 4-(2-(3-(3-Chloro-2-fluoro-6-(1H-tetrazol-1-yl)phenyl)acryloyl)-5-(4-methyl-2-oxopiperazin-1-yl)-1,2,3,4-tetrahydroisoquinoline-1-ca rboxamido)benzoic acid | C32H28ClFN8O5 | 1430114-34-3 | Details |
| Huntingtin antibody | Details |
| H-GTYSTTVTGR-OH | Details |
| (9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(di-tert-butylphosphine) | C31H48OP2 | 856405-77-1 | Details |
| GBP1 antibody | Details |
| Pitolisant hydrochloride | C17H26ClNO.HCl | 903576-44-3 | Details |
| methyl 7-butyl-1,3-dimethyl-2,4-dioxo-2,3,4,7-tetrahydro-1h-pyrrolo[2,3-d]pyrimidine-6-carboxylate | C14H19N3O4 | 1086386-32-4 | Details |
| 6-Methyl-2-oxo-5-phenyl-1,2-dihydropyridine-3-carboxylic acid | C13H11NO3 | 10176-79-1 | Details |
| (2-Methoxyphenyl)methanethiol | C8H10OS | 874988-61-1 | Details |
| H-AEQASQEVKNW-OH | Details |
| Recombinant Rat IL-17 | Details |
| Ipconazole | C18H24ClN3O | 125225-28-7 | Details |
| tert-Butyl 3,4-diaminobenzoate | C11H16N2O2 | 62754-26-1 | Details |
| 3-Hydroxymethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazine-7-carboxylic acid tert-butylester | C11H18N4O3 | 1251002-77-3 | Details |
| [Arg8]-Vasopressin (Human, Bovine, Ovine, Rat, Mouse) (0.5 mg vial) | C46H65N15O12S2 | 113-79-1 | Details |
| (2R,3S)-3-Hydroxy-2,4-dimethylpentanoic acid | C7H14O3 | 77341-63-0 | Details |
| (2E)-3-[1-(1,3-Dioxaindan-5-yl)-2,5-dimethyl-1H-pyrrol-3-yl]prop-2-enoic acid | C16H15NO4 | 851879-23-7 | Details |
| 3,5-Dimethyl-1H-pyrazole-4-sulfonamide | C5H9N3O2S | 88398-54-3 | Details |
| H-FSVTTMR-OH | Details |
| Bis(2,2,2-trifluoroethyl) sulfite | C4H4F6O3S | 53749-89-6 | Details |
| p16 INK4 alpha protein | Details |
| 4,5,6,7-Tetrahydro-1-benzothiophen-4-amine | C8H11NS | 58094-17-0 | Details |
| Chikusetsusaponin V methyl ester | C49H78O19 | 34291-22-0 | Details |
| GJA4 Blocking Peptide | Details |
| 1-Bromo-4-[difluoro(methoxy)methyl]benzene | C8H7BrF2O | 1236031-38-1 | Details |
| Isomaltulose | C12H22O11 | 13718-94-0 | Details |
| rac-tert-butyl N-[(3R,4S)-4-aminooxolan-3-yl]carbamate | C9H18N2O3 | 1629586-23-7 | Details |
| 2,4-Difluoro-5-(2-methylpropanamido)benzoic acid | C11H11F2NO3 | 1183740-54-6 | Details |
| [(2,3-Dihydro-1-benzofuran-3-yl)methyl](methoxy)amine hydrochloride | C10H14ClNO2 | 2059954-43-5 | Details |
| 2-[(1-Methyl-1H-imidazol-2-yl)sulfanyl]pyridine-4-carboximidamide hydrochloride | C10H12ClN5S | 1221722-16-2 | Details |
| 2,3,4,6-Tetra-O-pivaloyl-D-glucopyranosyl amine | C26H45NO9 | 888963-33-5 | Details |
| Biotin-cysteamine | C12H21N3O2S2 | 99938-68-8 | Details |
| 5,7,2'-Trimethoxyflavone | C18H16O5 | 4308-57-0 | Details |
| 3-Bromo-2-methylthieno[2,3-c]pyridin-7(6H)-one | C8H6BrNOS | 1360944-19-9 | Details |
| Monomethyl lithospermate | C28H24O12 | 933054-33-2 | Details |
| H-RPGLLGASVLGLDDI-OH | Details |
| 2-[4-Methoxy-3-(methylsulfanyl)phenyl]acetonitrile | C10H11NOS | 1311316-24-1 | Details |
| 1-Cyclobutyl-5-oxopyrrolidine-3-carboxylic acid | C9H13NO3 | 1223748-42-2 | Details |
| S 9947 | C29H27N3O3 | 332378-43-5 | Details |
| [5-(Methylsulfanyl)furan-2-yl]methanamine hydrochloride | 2172559-10-1 | Details |
| HIV1 tat antibody | Details |
| 1-Chloro-N,N-dimethyl-propan-2-amine HCl | C5H13Cl2N | 17256-39-2 | Details |
| 7-Fluoro-8-methyl-1,2,3,4-tetrahydroquinoline | C10H12FN | 1248496-95-8 | Details |
| 1-(4-(trifluoromethoxy)phenyl)-3-benzoylthiourea | C15H11F3N2O2S | 163490-80-0 | Details |
| 4,6-Dimethyl-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid | C8H9NO3 | 24667-09-2 | Details |
| 6-(Trimethylsilyl)pyridin-3-amine | C8H14N2Si | 939767-74-5 | Details |
| Methyl 5-aminothiazole-4-carboxylate | C5H6N2O2S | 1239464-24-4 | Details |
| 5-Carbamoylfuran-3-carboxylic acid | C6H5NO4 | 1461706-08-0 | Details |
| 2-(((1,3-dioxoindan-2-ylidene)methyl)amino)-5-methylbenzoic acid | C18H13NO4 | 959579-16-9 | Details |
| 3-(3-Oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)propanoic acid | C11H11NO4 | 1268047-11-5 | Details |
| Pss-allyl-heptacyclopentyl substituted | C38H68O12Si8 | 205131-81-3 | Details |
| 6,7-Dimethyl-2,3-dihydro-1H-inden-1-one | C11H12O | 16440-98-5 | Details |
| 3-(2-Fluorophenyl)azetidine hydrochloride | C9H11ClFN | 1203686-39-8 | Details |
| 2-(2-Methoxyethyl)-1,3-dithiane | C7H14OS2 | 938184-26-0 | Details |
| FRK Blocking Peptide | Details |
| N,1-Dimethyl-1H-pyrazol-5-amine hydrochloride | C5H10ClN3 | 1334146-41-6 | Details |
| Ethyl trans-2-cyanocyclopropane-1-carboxylate | C7H9NO2 | 3999-56-2 | Details |
| ((2-(2-Chloroethoxy)ethoxy)methyl)benzene | C11H15ClO2 | 64352-98-3 | Details |
| N-[2-Aminoethyl) lenalidomide trifluoroacetic acid salt | C15H18N4O3 | 2138444-73-0 | Details |
| 5-Methoxy-1-naphthoic acid | C12H10O3 | 51934-37-3 | Details |
| VSTM2A antibody | Details |
| N-Methyl-N-(2,2,2-trifluoroethyl)piperidin-4-amine hydrochloride | C8H16ClF3N2 | 1432678-56-2 | Details |
| 4-Cyano-1-phenylpyrazole | C10H7N3 | 709-04-6 | Details |
| H-NSSNYCCELCCNPACTGCY-OH | C79H112N22O30S6 | 118447-40-8 | Details |
| 3-Bromo-1,2,4-thiadiazole | C2HBrN2S | 1036990-54-1 | Details |
| C1qtnf2 antibody | Details |
| 5-Amino-6-chloro-3-methyl-3,4-dihydropyrimidin-4-one | C5H6ClN3O | 63291-60-1 | Details |
| 1-(2',3',5'-Tri-O-tert-butyldimethylsilyl-b-D-ribofuranosyl)-5-ethynylimidazo-4-carbonitrile | C29H53N3O4Si3 | 147212-83-7 | Details |
| 4-(3-Aminophenoxy)benzonitrile | C13H10N2O | 30202-93-8 | Details |
| H-VGVNGFGR^-OH | Details |
| 2-{[4-(4-Methoxybenzenesulfonamido)phenyl]formamido}acetic acid | C16H16N2O6S | 795293-19-5 | Details |
| H-Pro-Phe-NH2·HCl | C14H20ClN3O2 | 97372-02-6 | Details |
| N-[1-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)ethyl]cyclopropanamine hydrochloride | C14H20ClNO2 | 1197886-48-8 | Details |
| [(2-Bromo-5-fluorophenyl)methyl](methyl)amine hydrochloride | C8H10BrClFN | 1645529-42-5 | Details |
| 3-Amino-1-(2-fluorophenyl)pyrrolidin-2-one | C10H11FN2O | 1247157-86-3 | Details |
| PBK Blocking Peptide | Details |
| N1-Methyl-N1-(propan-2-yl)benzene-1,2-diamine dihydrochloride | C10H17ClN2 | 1803588-75-1 | Details |
| Methyl[2-(1,2,4-oxadiazol-3-yl)ethyl]amine hydrochloride | C5H10ClN3O | 1390654-65-5 | Details |
| FUT6 Blocking Peptide | Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 | ||||